Cellular magnetic resonance imaging: Current status and future prospects

Ali Syed Arbab, Wei Liu, Joseph A. Frank

Research output: Contribution to journalReview article

118 Citations (Scopus)

Abstract

Cellular magnetic resonance imaging (CMRI) allows for the tracking of the temporal and spatial migration of cells labeled with MR contrast agents within organs and tissues. This rapidly growing area of experimental research has the potential of translating from bench to bedside and may be used in conjunction with cellular therapy clinical trials or in the evaluation of novel drug therapies. Ex vivo labeling of nonphagocytic cells with superparamagnetic iron oxide nanoparticles or paramagnetic contrast agents (i.e., gadolinium or manganese) allows for the detection of single cells or clusters of labeled cells within target tissues using CMRI following either direct implantation or intravenous injection. However, prior to the translation of experimental cell labeling studies to clinical trials, it is essential to perform preclinical evaluation to demonstrate a lack of toxicity, the ability to scale-up labeling using good manufacturing practice and the ability to detect cells by in vivo MRI in relevant model systems.

Original languageEnglish (US)
Pages (from-to)427-439
Number of pages13
JournalExpert Review of Medical Devices
Volume3
Issue number4
DOIs
StatePublished - Jul 1 2006

Fingerprint

Magnetic resonance
Labeling
Magnetic Resonance Imaging
Imaging techniques
Tissue
Drug therapy
Gadolinium
Contrast Media
Iron oxides
Magnetic resonance imaging
Manganese
Toxicity
Clinical Trials
Cells
Nanoparticles
Intravenous Injections
Cell Movement
Drug Therapy
Research

Keywords

  • Cell tracking
  • Cellular MRI
  • Gene delivery
  • SPIO
  • Stem cells

ASJC Scopus subject areas

  • Surgery
  • Biomedical Engineering

Cite this

Cellular magnetic resonance imaging : Current status and future prospects. / Arbab, Ali Syed; Liu, Wei; Frank, Joseph A.

In: Expert Review of Medical Devices, Vol. 3, No. 4, 01.07.2006, p. 427-439.

Research output: Contribution to journalReview article

@article{e7b64b024853418bacbd39a606d13dbe,
title = "Cellular magnetic resonance imaging: Current status and future prospects",
abstract = "Cellular magnetic resonance imaging (CMRI) allows for the tracking of the temporal and spatial migration of cells labeled with MR contrast agents within organs and tissues. This rapidly growing area of experimental research has the potential of translating from bench to bedside and may be used in conjunction with cellular therapy clinical trials or in the evaluation of novel drug therapies. Ex vivo labeling of nonphagocytic cells with superparamagnetic iron oxide nanoparticles or paramagnetic contrast agents (i.e., gadolinium or manganese) allows for the detection of single cells or clusters of labeled cells within target tissues using CMRI following either direct implantation or intravenous injection. However, prior to the translation of experimental cell labeling studies to clinical trials, it is essential to perform preclinical evaluation to demonstrate a lack of toxicity, the ability to scale-up labeling using good manufacturing practice and the ability to detect cells by in vivo MRI in relevant model systems.",
keywords = "Cell tracking, Cellular MRI, Gene delivery, SPIO, Stem cells",
author = "Arbab, {Ali Syed} and Wei Liu and Frank, {Joseph A.}",
year = "2006",
month = "7",
day = "1",
doi = "10.1586/17434440.3.4.427",
language = "English (US)",
volume = "3",
pages = "427--439",
journal = "Expert Review of Medical Devices",
issn = "1743-4440",
publisher = "Expert Reviews Ltd.",
number = "4",

}

TY - JOUR

T1 - Cellular magnetic resonance imaging

T2 - Current status and future prospects

AU - Arbab, Ali Syed

AU - Liu, Wei

AU - Frank, Joseph A.

PY - 2006/7/1

Y1 - 2006/7/1

N2 - Cellular magnetic resonance imaging (CMRI) allows for the tracking of the temporal and spatial migration of cells labeled with MR contrast agents within organs and tissues. This rapidly growing area of experimental research has the potential of translating from bench to bedside and may be used in conjunction with cellular therapy clinical trials or in the evaluation of novel drug therapies. Ex vivo labeling of nonphagocytic cells with superparamagnetic iron oxide nanoparticles or paramagnetic contrast agents (i.e., gadolinium or manganese) allows for the detection of single cells or clusters of labeled cells within target tissues using CMRI following either direct implantation or intravenous injection. However, prior to the translation of experimental cell labeling studies to clinical trials, it is essential to perform preclinical evaluation to demonstrate a lack of toxicity, the ability to scale-up labeling using good manufacturing practice and the ability to detect cells by in vivo MRI in relevant model systems.

AB - Cellular magnetic resonance imaging (CMRI) allows for the tracking of the temporal and spatial migration of cells labeled with MR contrast agents within organs and tissues. This rapidly growing area of experimental research has the potential of translating from bench to bedside and may be used in conjunction with cellular therapy clinical trials or in the evaluation of novel drug therapies. Ex vivo labeling of nonphagocytic cells with superparamagnetic iron oxide nanoparticles or paramagnetic contrast agents (i.e., gadolinium or manganese) allows for the detection of single cells or clusters of labeled cells within target tissues using CMRI following either direct implantation or intravenous injection. However, prior to the translation of experimental cell labeling studies to clinical trials, it is essential to perform preclinical evaluation to demonstrate a lack of toxicity, the ability to scale-up labeling using good manufacturing practice and the ability to detect cells by in vivo MRI in relevant model systems.

KW - Cell tracking

KW - Cellular MRI

KW - Gene delivery

KW - SPIO

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=33746658566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746658566&partnerID=8YFLogxK

U2 - 10.1586/17434440.3.4.427

DO - 10.1586/17434440.3.4.427

M3 - Review article

C2 - 16866640

AN - SCOPUS:33746658566

VL - 3

SP - 427

EP - 439

JO - Expert Review of Medical Devices

JF - Expert Review of Medical Devices

SN - 1743-4440

IS - 4

ER -